Coastal Bridge Advisors, LLC Entera Bio Ltd. Transaction History

Coastal Bridge Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 07, 2019	SELL	$2.92 - $4.4 $175,375 - $264,264	-60,060 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$3.01 - $4.84 $180,780 - $290,690	60,060 New	60,060 $249,000

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $60.2M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.